Blockade of LIGHT/LTβ and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease

Journal of Clinical Investigation

Volumn 109, Issue 4, 2002, Pages 549-557

  Tamada, Koji ^a   Tamura, Hideto ^a   Flies, Dallas ^a   Fu, Yang Xin ^b   Celis, Esteban ^a   Pease, Larry R ^a   Blazar, Bruce R ^c   Chen, Lieping ^a,d  

^a MAYO GRADUATE SCHOOL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD40 ANTIGEN; CD40 LIGAND; LYMPHOTOXIN; LYMPHOTOXIN BETA RECEPTOR IMMUNOGLOBULIN; PROTEIN LIGHT; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; HERPESVIRUS ENTRY MEDIATOR LIGAND; LTB PROTEIN, MOUSE; LYMPHOTOXIN BETA; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; TNFSF14 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL TRANSFER; CLONAL ANERGY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GRAFT VERSUS HOST REACTION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; ANIMAL; C57BL MOUSE; CONGENIC STRAIN; DBA MOUSE; DRUG ANTAGONISM; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; CD40 LIGAND; CLONAL ANERGY; FEMALE; GRAFT VS HOST DISEASE; IMMUNOSUPPRESSION; ISOANTIGENS; LYMPHOTOXIN-ALPHA; LYMPHOTOXIN-BETA; MEMBRANE PROTEINS; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85047686597     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0213604     Document Type: Article

References (46)

1. T cell depletion for graft-versus-host-disease prophylaxis. A perspective on engraftment in mice and humans
2. CD28/B7 system of T cell costimulation
3. Transplantation of anergic histoincompatible bone marrow allografts
4. In vivo blockade of CD28/CTLA4:B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice
5. Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells
6. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease
7. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients
8. Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation
9. Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT costimulatory pathway
10. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response
11. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator
12. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis
13. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes
14. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
15. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines
16. CD40 and its ligand in host defense
17. CD40 and CD154 in cell-mediated immunity
18. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells
19. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
20. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
21. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40
22. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation
23. Cutting edge: Sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease
24. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28
25. + T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses
26. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells
27. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins
28. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
29. Lymphocyte life-span and memory
30. T cell receptor antagonist peptides induce positive selection
31. Peripheral T cell tolerance
32. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences
33. Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice
34. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: Features of CD8+ and CD4+ T cell responses
35. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells
36. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues
37. Turning off follicular dendritic cells
38. Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells
39. Visualization, fate, and pathogenicity of antigen-specific CD8+ T cells in the graft-versus-host reaction
40. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model
41. Characterization of apoptosis-resistant antigen-specific T cells in vivo
42. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement
43. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
44. CD4+CD25+ immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade
45. Modifications of CD8+ T cell function during in vivo memory or tolerance induction
46. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway